Explore UAB

Aguilar Calvo Laboratory

Aguilar Calvo Laboratory

Patricia Aguilar Calvo D.V.M, Ph.D., is an assistant professor of Neurology. Her lab studies the factors that modulate the interaction of misfolded proteins with glycoproteins and the impact in the pathogenesis of prion and Parkinson's diseases.

Arrant Laboratory

Arrant Laboratory

Andrew Arrant, Ph.D., is an Assistant Professor of Neurology. His laboratory is focused on the cellular mechanisms underlying Alzheimer's disease and frontotemporal dementia.

Lab Site

Cowell Laboratory

Cowell Laboratory

Rita Cowell, Ph.D., is a Professor of Neurology. Her laboratory is focused on identifying the mechanisms underlying cell death in Parkinson's Disease, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis using mouse models of disease.

De Miranda Laboratory

De Miranda Laboratory

Briana De Miranda, Ph.D., is an Assistant Professor of Neurology. Her laboratory is focused on the role of environmental toxins in the pathogenesis of Parkinson disease.

Lab Site

Goldberg Laboratory

Goldberg Laboratory

Dr. Goldberg is an Associate Professor of Neurology. His laboratory is focused on identifying the mechanisms of neuronal degeneration in Parkinson's disease and investigating the roles of mitochondrial dysfunction, oxidative stress and genetic mutations in Parkin, DJ-1, PINK1, alpha-synuclein and LRRK2 that cause inherited forms of Parkinson’s disease

Lab Site

Gray Laboratory

Gray Laboratory

Dr. Gray's laboratory focuses on Huntington’s disease, a rare and fatal genetic degenerative disorder. Her goal is to identify and understand mechanisms that contribute to Huntington’s disease pathology.

Lab Site

Harms Laboratory

Harms Laboratory

Ashley Harms, Ph.D., is an Assistant Professor of Neurology. Her laboratory is focused on the role of neuroinflammation in Parkinson disease and related disorders including multiple system atrophy.

Lab Site

Herskowitz Laboratory

Herskowitz Laboratory

Dr. Herskowitz is an Assistant Professor of Neurology. His laboratory is focused on Alzheimer's disease and the development of novel therapeutic strategies to delay or prevent disease onset.

Lab Site

King Laboratory

King Laboratory

The King Lab is focused on mechanisms of growth factor mRNA stabilization in malignant gliomas and amyotrophic lateral sclerosis (ALS). Dr. King is also interested in molecular signatures of ALS in skeletal muscle. His long term goals are to identify potential therapeutic targets and to characterize biomarkers that may help in diagnosis and clinical monitoring.

Lab Site

Lazar Laboratory

Lazar Laboratory

Dr. Lazar holds the Evelyn F. McKnight Endowed Chair in Learning and Memory. His laboratory investigates the cognitive effects of cerebrovascular disease, and the impact of systemic disease on neuroinflammation and cognition in aging.

Lab Site

Limdi Laboratory

Limdi Laboratory

The Limdi Lab's primary research focus is to elucidate genetic and environmental determinants of drug response, specifically those that are associated with toxicity and lack of efficacy. Her goal is to identify genetic and environmental predictors of anticoagulant and antiplatelet response and use this information to individualize therapy.
Nabors Laboratory

Nabors Laboratory

The Nabors Lab studies the role of post-transcriptional regulation of gene expression in primary brain cancers. The lab is focused on RNA binding proteins and their ability to regulate cell growth, proliferation, and invasion.
Payami Laboratory

Payami Laboratory

Dr. Payami is a Professor in Neurology. Her laboratory is focused on the prevention and treatment of Parkinson's disease and in particular the genes that interact with environmental risk factors. The goal is to predict who is at risk and what they should avoid and further personalize individual treatment for maximum benefit.

Lab Site

Roberson Laboratory

Roberson Laboratory

Dr. Roberson’s primary interest is age-related memory disorders and neurodegenerative disease, including Alzheimer's disease and frontotemporal dementia.

Lab Site

Standaert Laboratory

Standaert Laboratory

Dr. Standaert's lab is interested in the pharmacology and neurochemistry of the basal ganglia and the mechanisms of Parkinson's disease and other conditions which produce abnormalities of movement.

Lab Site

Ubogu Laboratory

Ubogu Laboratory

The Ubogu Lab, the Neuromuscular Immunopathology Research Laboratory, is interested in the molecular biology and physiology of the human blood-nerve barrier, as well as mechanisms of leukocyte trafficking into the peripheral nervous system in health and in immune-mediated disorders such as Guillain-Barre-syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, vasculitic neuropathy and neuropathies associated with human immunodeficiency virus infection.

Lab Site

Volpicelli-Daley Laboratory

Volpicelli-Daley Laboratory

Laura Volpicelli-Daley, Ph.D., is an Associate Professor of Neurology. Her laboratory is focused on determining how α-synuclein pathology found in Parkinson's disease and Dementia with Lewy Bodies impacts membrane traffic in neurons, as well as how genes implicated in Parkinson's disease impact α-synuclein pathology.

Lab Site

Walker Laboratory

Walker Laboratory

The Walker lab investigates how deep brain stimulation works using a multimodal approach that integrates electroencephalography, electrocorticography, single unit recordings, neuroimaging, and behavioral assessment in patients with movement disorders. Our goal is to obtain new knowledge about the therapeutic mechanism of DBS and to apply these findings to guide technological innovation, both for established indications and for emerging indications in neurology and psychiatry.

Lab Site

Yacoubian Laboratory

Yacoubian Laboratory

The Yacoubian Lab is focused on understanding the pathophysiology of Parkinson’s disease with the long-term goal of developing neuroprotective therapies.

Lab Site

CNET Laboratories

The Center for Neurodegeneration and Experimental Therapeutics (CNET) is devoted to finding therapies for neurodegenerative diseases, including Alzheimer’s disease and related dementias, Parkinson’s disease, Huntington’s disease, and ALS. Its core goal is to promote the discovery of novel treatments for neurodegenerative disorders through basic and translational research, to teach scientists and clinicians about these diseases, and to facilitate the application of these discoveries to clinical care of patients.

Lab Site